TCL Archive FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat. February 6, 2004
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive Senate Democrats Include $1 Billion Boost To NIH In Economic Stimulus Package. November 21, 2008
TCL Archive FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic September 10, 1976
